Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes

References

• MacNeeWPulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary diseaseProc Am Thorac Soc200521506016113469
   PubMedGoogle Scholar
• SpruitMASinghSJGarveyCAn official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitationAm J Respir Crit Care Med20131888e13e6424127811
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• ZhongLZhangYPFuWPDaiLMSunCWangYQThe relationship between GSTP1 I105V polymorphism and COPD: a reappraisalAm J Respir Crit Care Med2010181776376520335387
   PubMed Web of Science ®Google Scholar
• ZhongLFuWPSunCDaiLMZhangYPAbsence of association between SERPINE2 genetic polymorphisms and chronic obstructive pulmonary disease in Han Chinese: a case-control cohort studyBMC Med Genet2009106619604412
   PubMed Web of Science ®Google Scholar
• FuWPSunCDaiLMYangLFZhangYPRelationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese populationOncol Rep200717248348817203192
   PubMed Web of Science ®Google Scholar
• LiHFuWPHongZHMicrosomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: a comprehensive meta-analysisOncol Lett2013531022103023426996
   PubMed Web of Science ®Google Scholar
• DekhuijzenPNAntioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary diseaseEur Respir J200423462963615083766
   PubMed Web of Science ®Google Scholar
• UenoTYamadaMIgarashiYOgawaTN-acetyl cysteine protects osteoblastic function from oxidative stressJ Biomed Mater Res A201199452353121913320
   PubMed Web of Science ®Google Scholar
• van OverveldFJDemkowUGoreckaDde BackerWAZielinskiJNew developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteineJ Physiol Pharmacol200556Suppl 413514216204787
   PubMedGoogle Scholar
• GerritsCMHeringsRMLeufkensHGLammersJWN-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary diseaseEur Respir J200321579579812765423
   PubMed Web of Science ®Google Scholar
• PelaRCalcagniAMSubiacoSIsidoriPTubaldiASanguinettiCMN-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPDRespiration199966649550010575333
   PubMed Web of Science ®Google Scholar
• TseHNRaiteriLWongKYHigh-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE studyChest2013144110611823348146
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
   PubMed Web of Science ®Google Scholar
• StavDRazMEffect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled studyChest2009136238138619447919
   PubMed Web of Science ®Google Scholar
• SchermerTChavannesNDekhuijzenRFluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitisRespir Med2009103454255119138505
   PubMed Web of Science ®Google Scholar
• DecramerMRutten-van MolkenMDekhuijzenPNEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet200536594701552156015866309
   PubMed Web of Science ®Google Scholar
• SmithCAHarrisonDJAssociation between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysemaLancet199735090786306339288046
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyStandardization of Spirometry, 1994 UpdateAm J Respir Crit Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• ParkJYChenLWadhwaNTockmanMSPolymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPDInt J Mol Med200515344344815702235
   PubMed Web of Science ®Google Scholar
• RodriguezFJardiRCostaXDetection of polymorphisms at exons 3 (Tyr113 – >His) and 4 (His139 – >Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysisAnal Biochem2002308112012612234472
   PubMed Web of Science ®Google Scholar
• SandfordAJChaganiTWeirTDConnettJEAnthonisenNRParePDSusceptibility genes for rapid decline of lung function in the lung health studyAm J Respir Crit Care Med2001163246947311179124
   PubMed Web of Science ®Google Scholar
• YoshikawaMHiyamaKIshiokaSMaedaHMaedaAYamakidoMMicrosomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in JapaneseInt J Mol Med200051495310601573
   PubMed Web of Science ®Google Scholar
• MaekawaKItodaMHaniokaNNon-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effectsXenobiotica200333327728712637245
   PubMed Web of Science ®Google Scholar
• HassettCAicherLSidhuJSOmiecinskiCJHuman microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variantsHum Mol Genet1994334214287516776
   PubMed Web of Science ®Google Scholar
• De BackerJVosWVan HolsbekeCEffect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patientsInt J Chron Obstruct Pulmon Dis2013856957924293993
   PubMed Web of Science ®Google Scholar
• ShenYCaiWLeiSZhangZEffect of high/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysisCOPD201411335135824378052
   PubMedGoogle Scholar
• SteyCSteurerJBachmannSMediciTCTramerMRThe effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic reviewEur Respir J200016225326210968500
   PubMed Web of Science ®Google Scholar
• SutherlandERCrapoJDBowlerRPN-acetylcysteine and exacerbations of chronic obstructive pulmonary diseaseCOPD20063419520217361500
   PubMedGoogle Scholar
• ZuinRPalamideseANegrinRCatozzoLScardaABalbinotMHigh-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary diseaseClin Drug Invest2005256401408
   PubMed Web of Science ®Google Scholar
• LomasDASilvermanEKThe genetics of chronic obstructive pulmonary diseaseRespir Res200121202611686861
   PubMed Web of Science ®Google Scholar
• SampsonasFKarkouliasKKaparianosASpiropoulosKGenetics of chronic obstructive pulmonary disease, beyond a1-antitrypsin deficiencyCurr Med Chem200613242857287317073633
   PubMed Web of Science ®Google Scholar
• ZhengJPKangJHuangSGEffect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled studyLancet200837196292013201818555912
   PubMed Web of Science ®Google Scholar